CLINICAL_TRIALS
trial_result
· 2026-01-07
Clinical Trial Update: Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer [Phase 2]
Summary
A Phase 2 clinical trial evaluating hybrid dose-fraction radiotherapy for metastatic non-small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Anhui Provincial Hospital | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED